KHPG(SZ:002773) Cai Jing Wang·2025-09-12 08:59Core Viewpoint - Kanghong Pharmaceutical is actively advancing its KH110 drug, currently in Phase III clinical trials, with an emphasis on market research and commercialization preparation to maximize its market value [1] Group 1: Drug Development - KH110 is in the Phase III clinical stage, indicating significant progress in its development timeline [1] - The timeline for the drug's market launch is influenced by various factors, leading to inherent uncertainties [1] Group 2: Market Potential - The commercial prospects of the innovative drug depend on multiple factors, including efficacy, safety, and market competition [1] - The company is committed to conducting market research and preparing for commercialization to enhance the market value of KH110 [1]